Back to List View Graph View

(S)-(−)-colchicine

(S)-(−)-colchicine is the naturally occurring, biologically active stereoisomer of colchicine and the form most commonly associated with the drug’s pharmacological effects.

Where the papers sit

10 papers from the last 6 months study (S)-(−)-colchicine directly · updated from PubMed 12 Nov 2026

  • Colchicine Therapeutic Applications

    Colchicine is being explored across knee osteoarthritis, hypertension, myocardial infarction, fibrosis, choriocarcinoma, and transdermal delivery. Randomized placebo-controlled testing and inflammatory or biochemical endpoints sit alongside targeted nanoplatforms and Raman-based release prediction. The studies do not establish a single therapeutic direction, and cancer screening findings remain separate from cardiovascular and osteoarthritis work. Shared emphasis is on repurposing colchicine while improving targeting, formulation, and evidence of benefit.

    6 papers · 60%

  • Cardiovascular Colchicine Therapy

    Low-dose colchicine is being evaluated beyond gout for cardiovascular risk reduction, especially in diabetes and coronary artery disease. Observational data link treatment in diabetic gout without prior coronary disease to lower all-cause mortality, while coronary studies examine microcalcification activity. Myocardial infarction and stroke recur as outcomes, but the evidence remains associative or mechanistic rather than definitive. The main open question is whether these signals translate into reduced cardiovascular events.

    2 papers · 20%

  • Microtubule-Targeting Cancer Therapy

    Colchicine-site microtubule inhibitors are being advanced as anticancer agents, aiming to trigger mitotic catastrophe rather than merely slow proliferation. Furan-trimethoxyphenyl hybrids and dual-acting 2-amino-3-cyanopyridines recur, with tubulin disruption linked to apoptosis in acute myeloid leukemia models. Potency is supported by inhibitory concentration measurements and xenograft activity, with cytarabine providing a relevant treatment context. Selectivity, resistance, and clinical translation remain unresolved.

    2 papers · 20%

(S)-(−)-colchicine chemical structure

Papers

The 10 papers from the last 6 months that study (S)-(−)-colchicine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Colchicine Therapeutic Applications (6)
  1. CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and biochemical outcomes from a three-month double-blind, placebo-controlled study. Seminars in arthritis and rheumatism · 1 Sept 2026 PMID 42679472
  2. Reshaping the cardiac microenvironment: a colchicine-loaded nanoplatform with lesion targeting and matrix penetration for myocardial fibrosis therapy. Biomaterials science · 27 Aug 2026 PMID 42657586
  3. Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma. Biochemical and biophysical research communications · 20 Jul 2026 PMID 42476068
  4. In Vitro Release Prediction of Colchicine Transdermal Patch Based on Raman Spectroscopy Imaging and Data-Driven Modeling. AAPS PharmSciTech · 17 Jun 2026 PMID 42310244
  5. Cardiac-homing peptide-targeted colchicine-based drugstores with inhibiting inflammatory response for myocardial infarction improvement. Materials today. Bio · 29 May 2026 PMID 42211057
  6. A Randomized Trial to Investigate the Effects of Low-Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT). Journal of clinical hypertension (Greenwich, Conn.) · 28 May 2026 PMID 42210033
Cardiovascular Colchicine Therapy (2)
  1. Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study. PloS one · 11 Nov 2026 PMID 43013613
  2. Influence of low-dose colchicine on coronary microcalcification activity in patients with diffuse coronary artery disease undergoing coronary artery bypass grafting: protocol for single-centre randomised open-label blinded-endpoint trial (the COL-CABG trial). BMJ open · 15 Sept 2026 PMID 42744364
Microtubule-Targeting Cancer Therapy (2)
  1. Discovery of furan-trimethoxyphenyl hybrids as novel colchicine-binding site inhibitors that induce mitotic catastrophe with potent anti-acute myeloid leukemia effect. Bioorganic chemistry · 19 Jun 2026 PMID 42320118
  2. Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK. Journal of medicinal chemistry · 16 Jun 2026 PMID 42298883

By study type

Clinical trials (3)
  1. Influence of low-dose colchicine on coronary microcalcification activity in patients with diffuse coronary artery disease undergoing coronary artery bypass grafting: protocol for single-centre randomised open-label blinded-endpoint trial (the COL-CABG trial). BMJ open · 15 Sept 2026 PMID 42744364
  2. CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and biochemical outcomes from a three-month double-blind, placebo-controlled study. Seminars in arthritis and rheumatism · 1 Sept 2026 PMID 42679472
  3. A Randomized Trial to Investigate the Effects of Low-Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT). Journal of clinical hypertension (Greenwich, Conn.) · 28 May 2026 PMID 42210033
Observational studies and case reports (1)
  1. Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study. PloS one · 11 Nov 2026 PMID 43013613
Preclinical: animal, cell and lab studies (5)
  1. Reshaping the cardiac microenvironment: a colchicine-loaded nanoplatform with lesion targeting and matrix penetration for myocardial fibrosis therapy. Biomaterials science · 27 Aug 2026 PMID 42657586
  2. Drug library screening identifies colchicine and shikonin as therapeutic candidates for methotrexate-resistant choriocarcinoma. Biochemical and biophysical research communications · 20 Jul 2026 PMID 42476068
  3. Discovery of furan-trimethoxyphenyl hybrids as novel colchicine-binding site inhibitors that induce mitotic catastrophe with potent anti-acute myeloid leukemia effect. Bioorganic chemistry · 19 Jun 2026 PMID 42320118
  4. In Vitro Release Prediction of Colchicine Transdermal Patch Based on Raman Spectroscopy Imaging and Data-Driven Modeling. AAPS PharmSciTech · 17 Jun 2026 PMID 42310244
  5. Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK. Journal of medicinal chemistry · 16 Jun 2026 PMID 42298883
Unclassified: not yet indexed with MeSH (1)
  1. Cardiac-homing peptide-targeted colchicine-based drugstores with inhibiting inflammatory response for myocardial infarction improvement. Materials today. Bio · 29 May 2026 PMID 42211057